Log In
Print
BCIQ
Print
Print this Print this
 

S-234462

  Manage Alerts
Collapse Summary General Information
Company Shionogi & Co. Ltd.
DescriptionOral neuropeptide Y receptor Y5 (NPY5R) antagonist
Molecular Target Neuropeptide Y receptor Y5 (NPY5R)
Mechanism of ActionNeuropeptide Y receptor Y5 (NPY5R) antagonist
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationObesity
Indication DetailsTreat obesity
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today